Embla Medical hf. (OSSFF)
OTCMKTS · Delayed Price · Currency is USD
4.850
0.00 (0.00%)
At close: Feb 9, 2026
Embla Medical Revenue
In the year 2025, Embla Medical had annual revenue of $928.69M with 8.63% growth. Embla Medical had revenue of $256.69M in the quarter ending December 31, 2025, with 14.20% growth.
Revenue
928.69M
Revenue Growth
+8.63%
P/S Ratio
2.20
Revenue / Employee
221.38K
Employees
4,195
Market Cap
2.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 928.69M | 73.80M | 8.63% |
| Dec 31, 2024 | 854.89M | 69.21M | 8.81% |
| Dec 31, 2023 | 785.68M | 67.03M | 9.33% |
| Dec 31, 2022 | 718.65M | -19.00K | - |
| Dec 31, 2021 | 718.67M | 89.17M | 14.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| OpGen | 9.00M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
Embla Medical News
- 8 days ago - Embla Medical hf. (OSSUY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Embla Medical hf: Interim Report Q4 and Full Year 2025 - PRNewsWire
- 4 months ago - Embla Medical hf. (OSSUY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Embla Medical hf (OSSFF) Q3 2025 Earnings Call Highlights: Strong Prosthetics Growth Amidst ... - GuruFocus
- 4 months ago - Embla Medical Net Profit Climbs In Q3, Confirms FY25 Outlook; Stock Up - Nasdaq
- 4 months ago - Embla Medical hf: Interim Report Q3 2025 - PRNewsWire
- 5 months ago - Embla Medical hf: Embla Medical closes the majority share investment in Streifeneder ortho.production GmbH - PRNewsWire
- 7 months ago - Embla Medical hf: Interim Report Q2 2025 - PRNewsWire